Finance

Beta
Lists
4893:TYO
Noile-Immune Biotech Inc
Â¥128.00
-0.78%
(-1.00) 1D
Jun 4, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4893...
Open
Â¥132
High
Â¥132
Low
Â¥128
Mkt. cap
5.56B
Avg. vol.
262.00K
Volume
98.90K
52-wk high
Â¥217
52-wk low
Â¥126
EPS
-Â¥16
No. of employees
23
Open
Â¥132
High
Â¥132
Low
Â¥128
Mkt. cap
5.56B
Avg. vol.
262.00K
Volume
98.90K
52-wk high
Â¥217
52-wk low
Â¥126
EPS
-Â¥16
No. of employees
23
News stories
From sources across the web
About Noile-Immune Biotech Inc
CEO-
Employees23
FoundedApr 16, 2015
Headquarters-
SectorBiotechnology
Websitenoile-immune.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.00M
1.00M
-
-
Cost of goods sold
-
-
52.00M
-
Cost of revenue
-
-
52.00M
-
Research and development expenses
73.00M
93.00M
72.00M
86.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.00M
104.00M
11.00M
116.00M
Operating expense
173.00M
197.00M
137.00M
202.00M
Total operating expenses
173.00M
197.00M
189.00M
202.00M
Operating income
-171.00M
-196.00M
-189.00M
-202.00M
Other non operating income
1.00M
-1.00M
1.00M
45.00M
EBT including unusual items
-170.00M
-193.00M
-188.00M
-153.00M
EBT excluding unusual items
-170.00M
-193.00M
-188.00M
-153.00M
Income tax expense
1.00M
1.00M
-
-
Effective tax rate
-0.59%
-0.52%
-
-
Other operating expenses
-
-
54.00M
-
Net income
-171.00M
-194.00M
-188.00M
-153.00M
Net profit margin
-8,550.00%
-19,400.00%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
4.00M
-
4.00M
Interest expense
-
-
-
-
Net interest expenses
-
4.00M
-
4.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer